| Talks： |
Guidelines for Home Sleep Apnea Testing by the Taiwan Society of Sleep Medicine
台灣睡眠醫學會居家睡眠呼吸中止症檢查指引 |
| Name： |
| 于鍾傑（Chung-Chieh Yu） |
| Position： |
| 主治醫師 |
| Affiliation： |
| 基隆長庚醫院胸腔科、睡眠中心 |
| Email： |
|
| Photo： |
 |
| Research Interests： |
| Pulmonary and Sleep medicine. |
| Selected Publications： |
1.Chung-Chieh Yu, Chih-Yu Huang, Chung-Ching Hua, Huang-Pin Wu. High-flow nasal cannula compared with continuous positive airway pressure in the treatment of obstructive sleep apnea. Sleep Breath. 2021 Jun 18. doi:10.1007/s11325-021-02413-0.
2. Chung-Yao Chen, Chia-Ling Chen, Chung-Chieh Yu. Trazodone improves obstructive sleep apnea after ischemic stroke: a randomized, double-blind, placebo-controlled, crossover pilot study. J Neurol. 2021 Feb 24. doi: 10.1007/s00415-021-10480-2. Chih-Yu Huang, Chung-Chieh Yu*. Different diagnostic criteria for periodic leg movements in patients with obstructive sleep apnea after continuous positive airway pressure titration. Neuropsychiatr Dis Treat. 2019 Jul 24;15:2129-2136. doi: 10.2147/NDT.S209806.
3. Chung-Chieh Yu, Chih-Yu Huang, Wei-Ke Kuo, Chung-Yao Chen. Continuous positive airway pressure improves nocturnal polyuria in ischemic stroke patients with obstructive sleep apnea. Clin Interv Aging. 2019; 14: 241–247. doi: 10.2147/CIA.S193448.
4. Chung-Yao Chen, Chien-Hui Ho, Chia-Ling Chen, Chung-Chieh Yu. Nocturnal Desaturation is Associated With Atrial Fibrillation in Patients With Ischemic Stroke and Obstructive Sleep Apnea. J Clin Sleep Med. 2017 May 15;13(5):729-735. doi: 10.5664/jcsm.6594.
5. Chung-Yao Chen, Chia-Ling Chen, Chung-Chieh Yu. Obstructive sleep apnea is independently associated with arterial stiffness in ischemic stroke patients. J Neurol. 2015 May; 262(5):1247-54.
6. Chung-Chieh Yu, Cheng-Ming Luo, Yu-Chih Liu, Huang-Pin Wu. The effects of heated humidifier in continuous positive airway pressure titration. Sleep Breath 2013;17:133-138.
|
| Abstract： |
Obstructive Sleep Apnea (OSA) affects approximately 15% of adults in Taiwan, presenting a significant public health challenge. The gold standard for diagnosing OSA has traditionally been the in-lab Polysomnography (PSG); however, the high prevalence of OSA and the associated costs and logistical challenges necessitate alternative diagnostic methods. Home Sleep Apnea Testing (HSAT) offers a cost-effective and efficient screening tool, particularly for adults at high risk for moderate to severe OSA without comorbidities.
The 2024 HSAT guidelines by the Taiwan Society of Sleep Medicine aim to provide sleep professionals with standardized procedures for utilizing HSAT in clinical practice. These guidelines emphasize the importance of proper patient selection, indicating HSAT primarily for those with a high risk of moderate to severe OSA and no significant comorbid conditions, such as central sleep apnea or severe cardiovascular diseases. The guidelines also delineate contraindications, including severe heart or lung diseases, opioid use, and uncontrolled psychiatric disorders.
HSAT equipment should be managed by qualified sleep technicians under the supervision of certified sleep physicians. The equipment must meet specific technical requirements, including the ability to record physiological parameters ensuring the data's diagnostic validity. Additionally, the guidelines recommend the involvement of sleep technicians in patient education, device setup, and data interpretation to reduce the incidence of test failures and enhance the accuracy of the results.
The 2024 guidelines provide a comprehensive framework for the effective and safe implementation of HSAT, ensuring high diagnostic accuracy while maintaining patient safety and data integrity. By adhering to these guidelines, sleep centers in Taiwan can enhance the management of OSA, offering timely and accessible care to patients in need.
|
| 2024年會： |
10/13 11:00 The Consensus on Home Sleep Apnea Testing by the Taiwan Society of Sleep Medicine
台灣睡眠醫學學會居家睡眠呼吸中止症檢查共識 [會議室3]
|